 General Electric Cos healthcare unit agreed to buy several lifescience businesses from Thermo Fisher Scientific Inc for about  billion its third biopharmaceutical acquisition in as many years The deal with GE expected to close early this year includes Thermo Fishers cellculture business which includes media and serums used to manufacture medicines and vaccines The businesses were put up for sale by Thermo Fisher late last year to expedite European approval of its pending  billion acquisition of Life
  